• Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
  • Team
  • Insights
    • Blog: Rock Island Review
    • News & Announcements
Menu
  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
  • Team
  • Insights
    • Blog: Rock Island Review
    • News & Announcements
Ti-linkedin
Portfolio

Ipinovyx Bio

Immunoproteasome modulating therapeutics to transform treatment of autoimmune and inflammatory diseases. PI: Gang Lin, Ph.D. and Carl Nathan, M.D. of Weill Cornell […]

adminFebruary 4, 2022
Portfolio

novosteo

Fracture targeting therapeutic for bone healing PI: Dr. Philip Low, Purdue University Visit site

adminAugust 21, 2020
Portfolio

morphimmune

Hyper-targeted small molecules for reprogramming immune cells to treat disease PI: Dr. Philip Low, Purdue University Visit site

adminAugust 21, 2020
Portfolio

erisyon

Single molecule protein sequencing PI: Dr. Edward Marcotte, University of Texas at Austin Visit site

adminAugust 21, 2020
Portfolio

eradivir

Targeted therapeutics platform for Infectious diseases PI: Dr. Philip Low, Purdue University

adminAugust 21, 2020
Portfolio

AsalyxaBio

ASX-100 neutrophil targeting platform to treat significant unmet medical needs PI: Dr. Lola Eniola-Adefeso, University of Michigan Visit site

adminAugust 20, 2020

About

  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
Menu
  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio

Insights

  • Rock Island Review
  • News & Announcements
Menu
  • Rock Island Review
  • News & Announcements

Company

  • Team
  • Contact
Menu
  • Team
  • Contact

Connect

Linkedin-in

© 2023 Research Bridge Partners. All rights reserved

 Twitter
 LinkedIn
 Email